<DOC>
	<DOCNO>NCT00568646</DOCNO>
	<brief_summary>To determine antitumor activity MKC-1 patient unresectable metastatic pancreatic cancer fail least one prior chemotherapy regimen either neoadjuvant , adjuvant , first-line metastatic setting</brief_summary>
	<brief_title>Phase 2 Study Oral MKC-1 Patients With Unresectable Metastatic Pancreatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Provide write informed consent Health Insurance Portability Accountability Act authorization release protect health information study relate assessment Have histologically confirm pancreatic cancer measurable disease accord RECIST Have fail least one prior chemotherapy regimen either neoadjuvant , adjuvant , firstline metastatic setting Be least 18 year age time consent Have Eastern Cooperative Oncology Group performance status 0 1 Have follow laboratory result , within 10 day first MKC 1 administration : 1 . Hemoglobin great equal 9 g/dL 2 . Absolute neutrophil count great equal 1.5 x 109 cells/L 3 . Platelet count great equal 75 x 109 cells/L 4 . Serum creatinine less equal 1.5 time upper limit normal ( ULN ) 5 . Aspartate transaminase less equal 2.5 time ULN 6 . Serum albumin great equal 3.0 g/dL 7 . Total bilirubin less equal ULN Be pregnant breastfeed woman . Female patient must postmenopausal , surgically sterile , must agree use barrier method contraception . Female patient childbearing potential must negative pregnancy test within 10 day first MKC 1 administration . Male patient must surgically sterile agree use acceptable method contraception . Have know central nervous system metastases unless treat , clinically stable , require use steroid . Have clinical evidence significant bowel obstruction , active uncontrolled malabsorption syndrome , history total gastrectomy . Have uncontrolled hypercalcemia ( serum calciumcorrected great 12 mg/dL ) . Have serious cardiac condition ( Class III/IV congestive heart failure accord New York Heart Association classification ) document acute myocardial infarction within previous 6 month . Have medical condition , investigator 's opinion , would impose excessive risk patient . These condition include : infection require parenteral oral antiinfective treatment alter mental status psychiatric condition would interfere understand informed consent . Have previous malignancy , unless free recurrence least 5 year except cure basal cell carcinoma skin carcinomainsitu uterine cervix . Be receive treatment antiretroviral therapy metabolize CYP3A4 ( include indinavir , nelfinavir , ritonavir , saquinavir , medication interfere CYP3A4 ) . Have , opinion investigator , clinically significant exist toxicity previous chemotherapy therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>